Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer



Status:Recruiting
Conditions:Lung Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:August 2007

Use our guide to learn which trials are right for you!

Paclitaxel Poliglumex (CT-2103)/Carboplatin vs Paclitaxel/Carboplatin for the Treatment of Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer (NSCLC) in Women With Estradiol >30 pg/mL

RATIONALE: Drugs used in chemotherapy, such as carboplatin, paclitaxel, and paclitaxel
poliglumex, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing. It is not yet known whether giving carboplatin
together with paclitaxel poliglumex is more effective than giving carboplatin together with
paclitaxel in treating non-small cell lung cancer.

PURPOSE: This randomized phase III trial is studying carboplatin and paclitaxel poliglumex
to see how well they work compared with carboplatin and paclitaxel in treating women with
stage III, stage IV, or recurrent non-small cell lung cancer.

OBJECTIVES:

Primary

- Compare the overall survival of patients with chemotherapy-naïve stage IIIB or IV or
recurrent non-small cell lung cancer treated with paclitaxel poliglumex and carboplatin
vs paclitaxel and carboplatin.

Secondary

- Compare the progression-free survival of women treated with these regimens.

- Compare the disease control in women treated with these regimens.

- Compare the clinical benefit in women treated with these regimens.

- Compare the response rate in women treated with these regimens.

- Compare the quality of life of women treated with these regimens.

- Compare the safety and tolerability in women treated with these regimens.

OUTLINE: This is a multicenter study.

Patients are stratified according to age (≥ 60 vs < 60 years old), geographical location
(United States of America, Canada, or Australia vs the rest of the world), extent of disease
(independent of brain metastases, i.e., brain metastases are not considered in determining
extent of disease) (intrathoracic disease only vs extrathoracic disease), and ECOG
performance status (0 or 1 vs 2). Patients will be randomized to 1 of 2 treatment arms.

- Arm I: Patients receive paclitaxel poliglumex IV over 10 minutes followed by
carboplatin IV over 30 minutes on day 1.

- Arm II: Patients receive paclitaxel IV over 3 hours followed by carboplatin IV over 30
minutes on day 1.

In both arms, treatment repeats every 21 days for up to 6 courses in the absence of disease
progression or unacceptable toxicity.

Quality of life is assessed at baseline, before each course, and at the completion of study
treatment by the Pain Assessment Patient Questionnaire, the Pulmonary Symptom Index, and the
Functional Assessment of Cancer Therapy- Lung Cancer Subscale (FACT-LCS) (only in countries
in which a validated translation is currently available).

After completion of study therapy, patients are followed at least monthly.

DISEASE CHARACTERISTICS:

- Histologically or cytologically confirmed diagnosis of non-small cell lung cancer
(NSCLC)

- Cytologic specimens obtained by brushings, washings, or needle aspiration of a
defined lesion or from a pleural effusion are acceptable; sputum cytology alone
is not acceptable for determining cell type

- Must meet one of the following criteria:

- Recurrent disease following completion of radiation or surgery

- Stage IIIB disease and not a candidate for combined modality therapy (primary
radiation therapy or surgery)

- Stage IV disease

- Patients may have either measurable or nonmeasurable disease according to RECIST
criteria

- Baseline estradiol > 30 pg/mL

- Patients on hormone replacement therapy are eligible provided baseline estradiol
> 30 pg/mL

- Patients with known brain metastases must have received standard antitumor treatment
(e.g. whole brain radiation, stereotactic radioablation, or surgery) for their CNS
metastases as defined by the site's institutional standards

- Neurologic function must have been stable for 2 weeks before randomization and
patients must either be off steroid therapy for their brain metastases or on a
tapering regimen

- Patients must have recovered from therapy for their brain metastases with no
evidence of significant unstable neurological symptoms within the 4 weeks before
study randomization

- No evidence of small cell carcinoma, carcinoid, or mixed small cell/non-small cell
histology

PATIENT CHARACTERISTICS:

- Female

- ECOG performance score 0-2

- Life expectancy ≥ 12 weeks

- Absolute neutrophil count ≥ 1,500/mm³

- Platelet count ≥ 100,000/mm³

- Hemoglobin ≥ 10 g/dL (may be achieved with transfusion)

- Creatinine ≤ 1.5 times upper limit of normal (ULN)

- Total bilirubin ≤ 1.5 times ULN (CTC grade 1) (patients with Gilbert syndrome or
other hereditary bilirubin defects may be included regardless of bilirubin levels)

- SGOT and SGPT ≤ 2.5 times ULN (CTC grade 0 or 1) (5 times ULN [CTC grade 0 to 2] if
due to liver metastases)

- Alkaline phosphatase ≤ 2.5 times ULN except for elevated alkaline phosphatase with
laboratory documentation that demonstrates bone origin

- No pregnant women or nursing mothers

- Negative pregnancy test

- Fertile patients must use effective contraception during and for 6 months after study
participation

- No known hypersensitivity to study drugs or excipients

- Meets all of the following criteria:

- No weight loss > 10% in previous 6 months

- Lactate dehydrogenase (LDH) ≤ 600 IU/L (central laboratory) regardless of weight
loss

- LDH ≤ 400 IU/L (central laboratory) and no weight loss ≥ 5% in previous 6 months

- BMI ≤ 35

- No concurrent primary malignancies except for carcinoma in situ or non-melanoma skin
cancer

- No neuropathy grade 2 or greater

- No clinically significant active infection for which active therapy is underway

- No unstable medical conditions including unstable angina or myocardial infarction
within the past 6 months

- Patients with evidence of cardiac conduction abnormalities are eligible if their
cardiac status is stable

- No circumstance that would preclude completion of the study or the required follow-up

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- Recovered from major surgery

- At least 7 days since prior local palliative radiotherapy

- At least 30 days since prior radiation therapy with curative intent

- At least 4 weeks since prior investigational therapy, unless local requirements are
more stringent

- No prior systemic chemotherapy for the treatment of lung cancer, including systemic
radiosensitizers used to treat brain metastases or any biologic agents

- No concurrent non-protocol-specified systemic antitumor therapy

- No concurrent amifostine, investigational agents, other cytotoxic agents for this
disease

- No concurrent radiotherapy (with the exception of radiotherapy for brain or bone
metastases for palliative purposes or radiotherapy for a condition other than NSCLC
that was ongoing at the time of randomization)

- Patients receiving palliative radiotherapy (treatment for symptomatic metastatic
disease) may be treated while on study
We found this trial at
41
sites
Staten Island, New York 10310
?
mi
from
Staten Island, NY
Click here to add this to my saved trials
2600 6th Street Southwest
Canton, Ohio 44710
330-452-9911
Aultman Cancer Center at Aultman Hospital Serving Stark and surrounding counties since 1892, Aultman Hospital...
?
mi
from
Canton, OH
Click here to add this to my saved trials
6405 N Federal Hwy # 300
Fort Lauderdale, Florida 33308
?
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
800 NE 10th Street
Oklahoma City, Oklahoma 73104
(855) 750-2273
Oklahoma University Cancer Institute The Peggy and Charles Stephenson Cancer Center is located on the...
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
40 Sunshine Cottage Road
Valhalla, New York 10595
(914) 594-4000
New York Medical College The College was founded in 1860 by a group of New...
?
mi
from
Valhalla, NY
Click here to add this to my saved trials
Abingdon, Virginia 24211
?
mi
from
Abingdon, VA
Click here to add this to my saved trials
?
mi
from
Austin, TX
Click here to add this to my saved trials
Austin, Texas 78759
?
mi
from
Austin, TX
Click here to add this to my saved trials
Bethlehem, Pennsylvania 18015
?
mi
from
Bethlehem, PA
Click here to add this to my saved trials
900 E Broadway Ave
Bismarck, North Dakota 58501
(701) 530-5550
Mid Dakota Clinic, PC We're your family clinic, with the doctors you know and trust...
?
mi
from
Bismarck, ND
Click here to add this to my saved trials
?
mi
from
Bronx, NY
Click here to add this to my saved trials
?
mi
from
Burbank, CA
Click here to add this to my saved trials
?
mi
from
Canfield, OH
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Cincinnati, Ohio 45267
513-584-7698
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Collierville, Tennessee 38077
?
mi
from
Collierville, TN
Click here to add this to my saved trials
?
mi
from
Columbia, MO
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Escondido, California 92025
?
mi
from
Escondido, CA
Click here to add this to my saved trials
?
mi
from
Free Soil, MI
Click here to add this to my saved trials
Germantown, Tennessee 38138
?
mi
from
Germantown, TN
Click here to add this to my saved trials
Greenville, South Carolina 29615
?
mi
from
Greenville, SC
Click here to add this to my saved trials
Hattiesburg, Mississippi 39401
?
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
Haute Terre, Indiana 47802
?
mi
from
Haute Terre, IN
Click here to add this to my saved trials
Hollywood, Florida 33021
?
mi
from
Hollywood, FL
Click here to add this to my saved trials
?
mi
from
Joliet, IL
Click here to add this to my saved trials
Kansas City, Missouri 64131
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
Las Vegas, Nevada 89102
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
?
mi
from
Montebello, CA
Click here to add this to my saved trials
?
mi
from
Naperville, IL
Click here to add this to my saved trials
New Albany, Indiana 47150
?
mi
from
New Albany, IN
Click here to add this to my saved trials
Ogden, Utah 84403
?
mi
from
Ogden, UT
Click here to add this to my saved trials
?
mi
from
Olympia Fields, IL
Click here to add this to my saved trials
?
mi
from
Reno, NV
Click here to add this to my saved trials
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Scottsdale, Arizona 85258
?
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Seattle, Washington 98119
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Seattle, Washington 98101
(888) 862-2737
Virginia Mason Medical Center Established in 1920, Virginia Mason began as an 80-bed hospital with...
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Southfield, Michigan 48275
?
mi
from
Southfield, MI
Click here to add this to my saved trials
Stanford, California 94305
?
mi
from
Stanford, CA
Click here to add this to my saved trials
?
mi
from
Vincennes, IN
Click here to add this to my saved trials